Formalin-fixed, paraffin-embedded human Ovarian Carcinoma stained with SUMO-1 Monoclonal Antibody (SPM571)
Formalin-fixed, paraffin-embedded human Ovarian Carcinoma stained with SUMO-1 Monoclonal Antibody (SPM571)

Anti-SUMO-1 Antibody Clone SPM571

$ 488.00
Please Select Product Options Below To View The Catalog Number.

SKU: 7341-MSM1X
Species: Human and Broad Species Reactivity
Tested Applications: Flow Cytometry, Immunofluorescence, Western Blot, Immunohistochemistry (IHC)
Available Conjugates: Unconjugated
Isotype: Mouse IgG1 kappa
Mass Spec Validated?: Not MS Validated

Product NumberDescriptionPrice
7341-MSM1X-P1 Size: 100 ug, Tag: Unconjugated
Shipping Information
In Stock.
Flat Rate Shipping Anywhere in the US: $45
Datasheets and Documentation
Product Datasheet
Certificate of Analysis and Tags (Coming Soon)
Lot Number:

Expiration Date:

Concentration (Write Lyophilized if Lyophilized):

Reconsitution Instructions (Leave Blank if Liquid):

Manufacture Date:

Purity:

Bioactivity (test results eg. IU/ml):


SKU: 7341-MSM1X-P1
SUMO-1 General Information
Alternate Names
Small ubiquitin-related modifier 1, SUMO1, SUMO-1
Molecular Weight
11.5kDa (Monomer); 90kDa (Heteromer)
Chromosomal Location
2q33.1
Curated Database and Bioinformatic Data
Gene SymbolSUMO1
Entrez Gene ID7341
Ensemble Gene IDENSG00000116030
RefSeq Protein Accession(s)NP_003343, NP_001005781, NP_001005782
RefSeq mRNA Accession(s)NM_003352, NM_001005782 NM_001005781
RefSeq Genomic Accession(s)NG_011679, NC_000002, NC_018913
UniProt ID(s)P55856, A0A024R3Z2, Q93068, P63165
UniGene ID(s)P55856, A0A024R3Z2, Q93068, P63165
HGNC ID(s)12502
Cosmic ID(s)SUMO1
KEGG Gene ID(s)hsa:7341
PharmGKB ID(s)PA37149
General Description of SUMO-1.
This MAb is specific to SUMO-1, shows no cross-reaction with either SUMO-2 or SUMO-3. The small ubiquitin-related modifier (SUMO) proteins, which include SUMO-1, SUMO-2, SUMO-3, belong to the ubiquitin-like protein family. Like ubiquitin, the SUMO proteins are synthesized as precursor proteins that undergo processing before conjugation to target proteins. Also, both utilize the E1, E2,, E3 cascade enzymes for conjugation. However, SUMO, ubiquitin differ with respect to targeting. Ubiquitination predominantly targets proteins for degradation, whereas sumoylation targets proteins to a variety of cellular processing, including nuclear transport, transcriptional regulation, apoptosis, protein stability. The unconjugated SUMO-1 protein localizes to the nuclear membrane.

Human and Broad Species Reactivity Anti-SUMO-1 Antibody Product Attributes

Species: Human and Broad Species Reactivity
Tested Applications: Flow Cytometry, Immunofluorescence, Western Blot, Immunohistochemistry (IHC).
Application Notes: Flow Cytometry (0.5-1ug of antibody/million cells in 0.1ml), Immunofluorescence (0.5-1ug of antibody/ml), Western Blot (0.5-1ug of antibody/ml), Immunohistochemistry (IHC) (Formalin-fixed) (0.5-1ug of antibody/ml for 30 minutes at RT)
Clonality: Monoclonal
Anti-SUMO-1 Antibody Clone: SPM571
Clone SPM571 Host and Isotype: Mouse IgG1 kappa
Anti-Human and Broad Species Reactivity SUMO-1 Positive Control Sample: Breast carcinoma
Cellular Localization of Antibody Predominantly nuclear with some cytoplasmic
Buffer and Stabilizer: 10mM PBS with 0.05% BSA & 0.05% azide.
Antibody Concentration: 200ug/ml
Antibody Purification Method:Protein A/G Purified
Immunogen: Recombinant human SUMO1 protein
Storage Conditions: Store at 2 to 8° C (refrigerate). Stable for 24 months when properly stored.

SUMO-1 Previously Observed Antibody Staining Patterns

Observed Subcellular, Organelle Specific Staining Data:

Anti-SUMO1 antibody staining is expected to be primarily localized to the nuclear bodies, nuclear membrane, nucleoli and nucleus.

Observed Antibody Staining Data By Tissue Type:

Variations in SUMO-1 antibody staining intensity in immunohistochemistry on tissue sections are present across different anatomical locations. An intense signal was observed in glandular cells in the adrenal gland, hematopoietic cells in the bone marrow, adipocytes in breast, respiratory epithelial cells in the bronchus, glandular cells in the duodenum, endometrium, epididymis, fallopian tube and gallbladder, macrophages in lung, pneumocytes in lung, respiratory epithelial cells in the nasopharynx, glandular cells in the parathyroid gland, decidual cells in the placenta, trophoblastic cells in the placenta, glandular cells in the rectum, myocytes in skeletal muscle, fibroblasts in skin, keratinocytes in skin, Langerhans in skin, melanocytes in skin, glandular cells in the small intestine, adipocytes in mesenchymal tissue, fibroblasts in mesenchymal tissue, cells in the seminiferous ducts in testis, germinal center cells in the tonsil, non-germinal center cells in the tonsil and urothelial cells in the urinary bladder. More moderate antibody staining intensity was present in glandular cells in the adrenal gland, hematopoietic cells in the bone marrow, adipocytes in breast, respiratory epithelial cells in the bronchus, glandular cells in the duodenum, endometrium, epididymis, fallopian tube and gallbladder, macrophages in lung, pneumocytes in lung, respiratory epithelial cells in the nasopharynx, glandular cells in the parathyroid gland, decidual cells in the placenta, trophoblastic cells in the placenta, glandular cells in the rectum, myocytes in skeletal muscle, fibroblasts in skin, keratinocytes in skin, Langerhans in skin, melanocytes in skin, glandular cells in the small intestine, adipocytes in mesenchymal tissue, fibroblasts in mesenchymal tissue, cells in the seminiferous ducts in testis, germinal center cells in the tonsil, non-germinal center cells in the tonsil and urothelial cells in the urinary bladder. Low, but measureable presence of SUMO-1 could be seen inglandular cells in the appendix, lymphoid tissue in appendix, glial cells in the caudate nucleus and cerebral cortex, bile duct cells in the liver and Leydig cells in the testis. We were unable to detect SUMO-1 in other tissues. Disease states, inflammation, and other physiological changes can have a substantial impact on antibody staining patterns. These measurements were all taken in tissues deemed normal or from patients without known disease.

Observed Antibody Staining Data By Tissue Disease Status:

Tissues from cancer patients, for instance, have their own distinct pattern of SUMO-1 expression as measured by anti-SUMO-1 antibody immunohistochemical staining. The average level of expression by tumor is summarized in the table below. The variability row represents patient to patient variability in IHC staining.

Sample Type breast cancer carcinoid cervical cancer colorectal cancer endometrial cancer glioma head and neck cancer liver cancer lung cancer lymphoma melanoma ovarian cancer pancreatic cancer prostate cancer renal cancer skin cancer stomach cancer testicular cancer thyroid cancer urothelial cancer
Signal Intensity ++ + ++ ++ + ++ ++ ++ + ++ ++ +++ ++ ++ + ++ ++ +++ ++ ++
SUMO1 Variability ++ ++ ++ ++ +++ ++ ++ +++ ++ ++ +++ ++ ++ ++ +++ ++ ++ ++ ++ +++

Limitations and Warranty

enQuire Bio's SUMO-1 Anti-Human Monoclonal is available for Research Use Only. This antibody is guaranteed to work for a period of two years when properly stored.

There are no reviews yet.

Be the first to review “Anti-SUMO-1 Antibody Clone SPM571”

Your email address will not be published. Required fields are marked *

Share a Protocol (View Reviewed Protocols Below)

Protocol Title

Materials

Methods

Notes


  protocol submission gif
enQuire Bio, LLC   8420 S Continental Divide Rd, #202   Littleton, CO 80127
Chat: See lower right corner. | enquire@enquirebio.com | Fax: 1-720-897-3730
Customer Service Available M-F 8AM-6PM MST or 24/7 Via Email

Anti-SUMO-1 Antibody Clone SPM571

https://enquirebio.com/wp-content/uploads/2017/10/enQuire-Bio-7341-MSM1X-P1-anti-SUMO-1-antibody-300x225.jpeg